Investor Type | Firm |
Industries | BioTech • HealthTech (& Fitness) • Life Science |
Investing | United States • United Kingdom |
NetScientific is an investment firm specializing in the commercialization of intellectual property (IP) from leading universities, teaching hospitals, and research institutes, with a focus on the United Kingdom and the United States. Their strategy centers on identifying and developing research and technologies within healthcare diagnostics for five chronic disease areas: Cardiovascular, Liver, Cancer, Metabolic, and Digital Health. NetScientific actively invests in early-stage companies with promising IP assets, offering not only funding but also strategic support and management expertise to nurture growth and innovation. They aim to generate superior returns for investors from fast-growing sectors such as Life Sciences, Sustainability, Industrials, Robotics & AI. Their investment model is capital efficient and includes syndicated investments, balance sheet investments, and deploying funds from their Funds practice. The firm takes a proactive management style by taking board positions, collaborating with co-investors, and providing value creation services such as fundraising support, investment readiness, exit readiness, IP strategy, corporate collaborations, financial functions, and senior executive placements. NetScientific places importance on investing in solutions that impact healthcare systems, renewable energy, resource efficiency, waste reduction, sustainable supply chains, and technological advancements in Industrials, Robotics, and AI. They aim to maximize stakeholder value with well-planned exit strategies, including M&A, IPOs, or sales to PE and other financial investors. With a hands-on approach, they focus on a select group of companies at a time, aiming to drive growth and secure sustainable returns for investors.